Search Results - "Sormani, M."

On the ridges, undulations, and streams in Gaia DR2: linking the topography of phase space to the orbital structure of an N-body bar by Fragkoudi, F, Katz, D, Trick, W, White, S D M, Di Matteo, P, Sormani, M C, Khoperskov, S, Haywood, M, Hallé, A, Gómez, A

“…ABSTRACT We explore the origin of phase-space substructures revealed by the second Gaia data release in the disc of the Milky Way, such as the ridges in the…”
Get full text

Scoring treatment response in patients with relapsing multiple sclerosis by Sormani, MP, Rio, J, Tintorè, M, Signori, A, Li, D, Cornelisse, P, Stubinski, B, Stromillo, ML, Montalban, X, De Stefano, N

“…Background: We employed clinical and magnetic resonance imaging (MRI) measures in combination, to assess patient responses to interferon in multiple sclerosis…”
Get full text

ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis by Montalban, X., Gold, R., Thompson, A. J., Otero‐Romero, S., Amato, M. P., Chandraratna, D., Clanet, M., Comi, G., Derfuss, T., Fazekas, F., Hartung, H. P., Havrdova, E., Hemmer, B., Kappos, L., Liblau, R., Lubetzki, C., Marcus, E., Miller, D. H., Olsson, T., Pilling, S., Selmaj, K., Siva, A., Sorensen, P. S., Sormani, M. P., Thalheim, C., Wiendl, H., Zipp, F.

“…Background and purpose Multiple sclerosis (MS) is a complex disease with new drugs becoming available in the past years. There is therefore a need for a…”
Get full text

The Star Formation Rate of the Milky Way as Seen by Herschel by Elia, D., Molinari, S., Schisano, E., Soler, J. D., Merello, M., Russeil, D., Veneziani, M., Zavagno, A., Noriega-Crespo, A., Olmi, L., Benedettini, M., Hennebelle, P., Klessen, R. S., Leurini, S., Paladini, R., Pezzuto, S., Traficante, A., Eden, D. J., Martin, P. G., Sormani, M., Coletta, A., Colman, T., Plume, R., Maruccia, Y., Mininni, C., Liu, S. J.

“…Abstract We present a new derivation of the Milky Way’s current star formation rate (SFR) based on the data of the Herschel InfraRed Galactic Plane Survey…”
Get full text

Dense molecular gas properties on 100 pc scales across the disc of NGC 3627 by Bešlić, I, Barnes, A T, Bigiel, F, Puschnig, J, Pety, J, Herrera Contreras, C, Leroy, A K, Usero, A, Schinnerer, E, Meidt, S E, Emsellem, E, Hughes, A, Faesi, C, Kreckel, K, Belfiore, F M C, Chevance, M, den Brok, J S, Eibensteiner, C, Glover, S C O, Grasha, K, Jimenez-Donaire, M J, Klessen, R S, Kruijssen, J M D, Liu, D, Pessa, I, Querejeta, M, Rosolowsky, E, Saito, T, Santoro, F, Schruba, A, Sormani, M C, Williams, T G

“…ABSTRACT It is still poorly constrained how the densest phase of the interstellar medium varies across galactic environment. A large observing time is required…”
Get full text

Intracortical lesions: Relevance for new MRI diagnostic criteria for multiple sclerosis by FILIPPI, M, ROCCA, M. A, CALABRESE, M, SORMANI, M. P, RINALDI, F, PERINI, P, COMI, G, GALLO, P

“…To generate and validate new MRI diagnostic criteria for multiple sclerosis (MS) taking into account not only white matter lesions but also intracortical…”
Get full text

Subgroups of multiple sclerosis patients with larger treatment benefits: a meta-analysis of randomized trials by Signori, A., Schiavetti, I., Gallo, F., Sormani, M. P.

“…Background and purpose No subgroups of patients with higher treatment effects have been clearly detected in multiple sclerosis (MS). The aim of the present…”
Get full text

Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes by DE STEFANO, N, GIORGIO, A, DINACCI, D, TEDESCHI, G, GASS, A, MONTALBAN, X, ROVIRA, A, THOMPSON, A, COMI, G, MILLER, D. H, FILIPPI, M, BATTAGLINI, M, ROVARIS, M, SORMANI, M. P, BARKHOF, F, KORTEWEG, T, ENZINGER, C, FAZEKAS, F, CALABRESE, M

“…To assess the time course of brain atrophy and the difference across clinical subtypes in multiple sclerosis (MS). The percent brain volume change (PBVC) was…”
Get full text

Surrogate endpoints for EDSS worsening in multiple sclerosis: A meta-analytic approach by SORMANI, M. P, BONZANO, L, ROCCATAGLIATA, L, MANCARDI, G. L, UCCELLI, A, BRUZZI, P

“…To evaluate whether the effects on potential surrogate endpoints, such as MRI markers and relapses, observed in trials of experimental treatments are able to…”
Get full text

Clinical activity after fingolimod cessation: disease reactivation or rebound? by Frau, J., Sormani, M. P., Signori, A., Realmuto, S., Baroncini, D., Annovazzi, P., Signoriello, E., Maniscalco, G. T., La Gioia, S., Cordioli, C., Frigeni, B., Rasia, S., Fenu, G., Grasso, R., Sartori, A., Lanzillo, R., Stromillo, M. L., Rossi, S., Forci, B., Cocco, E.

“…Background and purpose There is debate as to whether the apparent rebound after fingolimod discontinuation is related to the discontinuation itself or whether…”
Get full text

Functional changes in Duchenne muscular dystrophy: A 12-month longitudinal cohort study by MAZZONE, E, VASCO, G, FROSINI, S, BELLO, L, BONFIGLIO, S, ZUCCHINI, E, DE SANCTIS, R, SCUTIFERO, M, BIANCO, F, ROSSI, F, MOTTA, M. C, SACCO, A, SORMANI, M. P, DONATI, M. A, MONGINI, T, PINI, A, BATTINI, R, PEGORARO, E, PANE, M, GASPERINI, S, PREVITALI, S, NAPOLITANO, S, MARTINELLI, D, TORRENTE, Y, BRUNO, C, VITA, G, COMI, G, BERTINI, E, MERCURI, E, BERARDINELLI, A, MESSINA, S, D'AMICO, A, DOGLIO, L, POLITANO, L, CAVALLARO, F

“…The aim of the study was to assess different outcome measures in a cohort of ambulant boys with Duchenne muscular dystrophy (DMD) over 12 months in order to…”
Get full text

In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study by Agosta, F., Absinta, M., Sormani, M. P., Ghezzi, A., Bertolotto, A., Montanari, E., Comi, G., Filippi, M.

“…Cervical cord damage is likely to contribute to the accumulation of disability in multiple sclerosis (MS) and can be quantified in vivo using MRI. We used…”
Get full text

Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1a by Vrenken, H., Battaglini, M., de Vos, M. L., Nagtegaal, G. J., Teixeira, B. C. A., Seitzinger, A., Jack, D., Sormani, M. P., Uitdehaag, B. M. J., Versteeg, A., Comi, G., Kappos, L., De Stefano, N., Barkhof, F.

“…Objective Evaluate the effect of subcutaneous interferon β-1a (sc IFN β-1a) versus placebo on the evolution of T1-weighted MRI lesions and central brain…”
Get full text

Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis by SORMANI, M. P, LI, D. K, BRUZZI, P, STUBINSKI, B, CORNELISSE, P, ROCAK, S, DE STEFANO, N

“…In multiple sclerosis (MS), the aim of therapies is to prevent the accumulation of irreversible disability. This is difficult to assess given the short time…”
Get full text

First metallicity determination from near-infrared spectra for five obscured Cepheids discovered in the inner disc by Inno, L, Urbaneja, M A, Matsunaga, N, Bono, G, Nonino, M, Debattista, V P, Sormani, M C, Bergemann, M, da Silva, R, Lemasle, B, Romaniello, M, Rix, H-W

Get full text

Relevance of asymptomatic spinal MRI lesions in patients with multiple sclerosis by Zecca, C, Disanto, G, Sormani, MP, Riccitelli, GC, Cianfoni, A, Del Grande, F, Pravatà, E, Gobbi, C

“…Background: The impact of new asymptomatic spinal cord lesions (a-SL) in multiple sclerosis (MS) course is poorly characterized. Objective: The objective of…”
Get full text

Modelling Local Bubble analogs: synthetic dust polarization maps by Maconi, E, Soler, J D, Reissl, S, Girichidis, P, Klessen, R S, Hennebelle, P, Molinari, S, Testi, L, Smith, R J, Sormani, M C, Teh, J W, Traficante, A

“…ABSTRACT We present a study of synthetic observations of polarized dust emission at 353 GHz as seen by an observer within a cavity in the interstellar medium…”
Get full text

Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience by Mancardi, GL, Sormani, MP, Di Gioia, M, Vuolo, L, Gualandi, F, Amato, MP, Capello, E, Currò, D, Uccelli, A, Bertolotto, A, Gasperini, C, Lugaresi, A, Merelli, E, Meucci, G, Motti, L, Tola, MR, Scarpini, E, Repice, AM, Massacesi, L, Saccardi, R, Donnini, I, Bosi, A, Guidi, S, Bagigalupo, A, Bonzano, L, Bruzzi, P, Roccatagliata, L, Antenucci, R, Granella, F, Martino, G, Rottoli, M, Solaro, C, Salvi, F, Barilaro, A, Capobianco, M

“…Background: Over recent years numerous patients with severe forms of multiple sclerosis (MS) refractory to conventional therapies have been treated with…”
Get full text

A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper by Saccardi, R, Freedman, MS, Sormani, MP, Atkins, H, Farge, D, Griffith, LM, Kraft, G, Mancardi, GL, Nash, R, Pasquini, M, Martin, R, Muraro, PA

“…Background: Haematopoietic stem cell transplantation (HSCT) has been tried in the last 15 years as a therapeutic option in patients with poor-prognosis…”
Get full text

Time to first relapse as an endpoint in multiple sclerosis clinical trials by Sormani, MP, Signori, A, Siri, P, De Stefano, N

“…Background: The increasing number of effective therapies to treat multiple sclerosis (MS) raises ethical concerns for the use of placebo in clinical trials,…”
Get full text